An overview of nanosomes delivery mechanisms: trafficking, orders, barriers and cellular effects

References

• Kumar D, Sharma D, Singh G, et al. Lipoidal soft hybrid biocarriers of supramolecular construction for drug delivery. ISRN Pharm. 2012;2012:474830.
   PubMedGoogle Scholar
• Bhowmik A, Khan R, Ghosh MK. Blood brain barrier: a challenge for effectual therapy of brain tumors. Biomed Res Int. 2015;2015:320941
   PubMed Web of Science ®Google Scholar
• Kou L, Sun J, Zhai Y, et al. The endocytosis and intracellular fate of nanomedicines: implication for rational design. Asian J Pharm Sci. 2013;8:1–10.
   Google Scholar
• Buzea C, Pacheco II, Robbie K. Nanomaterials and nanoparticles: sources and toxicity. Biointerphases. 2007;2:MR17–MR71.
   PubMed Web of Science ®Google Scholar
• Gujral SS, Khatri S. A review on basic concept of drug targeting and drug carrier system. Int J Adv Pharm Biol Chem. 2013;2:130–136.
   Google Scholar
• Oh N, Park JH. Endocytosis and exocytosis of nanoparticles in mammalian cells. Int J Nanomedicine 2014;9(Suppl 1):51–63.
   PubMed Web of Science ®Google Scholar
• Kettler K, Veltman K, van de Meent D, et al. Cellular uptake of nanoparticles as determined by particle properties, experimental conditions, and cell type. Environ Toxicol Chem. 2014;33:481–492.
   PubMed Web of Science ®Google Scholar
• Murugan K, Choonara YE, Kumar P, et al. Parameters and characteristics governing cellular internalization and trans-barrier trafficking of nanostructures. Int J Nanomedicine. 2015;10:2191–2206.
   PubMed Web of Science ®Google Scholar
• Fröhlich E. The role of surface charge in cellular uptake and cytotoxicity of medical nanoparticles. Int J Nanomedicine 2012;7:5577–5591.
   PubMed Web of Science ®Google Scholar
• Tokarev AA, Alfonso A, Segev N. Overview of intracellular compartments and trafficking pathways. In: Segev N, editor. Trafficking inside cells: pathways, mechanisms and regulations. New York: Springer; 2009. p. 3–14.
   Google Scholar
• Sakhtianchi R, Minchin RF, Lee KB, et al. Exocytosis of nanoparticles from cells: role in cellular retention and toxicity. Adv Colloid Interface Sci. 2013;201-202:18–29.
   PubMed Web of Science ®Google Scholar
• Sakhrani NM, Padh H. Organelle targeting: third level of drug targeting. Drug Des Devel Ther. 2013;7:585–599.
   PubMed Web of Science ®Google Scholar
• Savi CR, Luo L, Eisenberg A, et al. Micellar nanocontainers distribute to defined cytoplasmic organelles. Science 2003;300:615e618.
   Web of Science ®Google Scholar
• Rozenzhak SM, Kadakia MP, Caserta TM, et al. Cellular internalization and targeting of semiconductor quantum dots. Chem Commun. 2005;17:2217–2219.
   PubMed Web of Science ®Google Scholar
• Jesus M, Berry CC. Tat peptide as an efficient molecule to translocate gold nanoparticles into the cell nucleus. Bioconjug Chem. 2005;16:1176–1180.
   PubMed Web of Science ®Google Scholar
• Hild W, Breunig M, Goepferich A. Quantum dots – nano-sized probes for the exploration of cellular and intracellular targeting . Eur J Pharm Biopharm. 2008;68:153–168.
   PubMed Web of Science ®Google Scholar
• Wang P, Wang X, Wang L, et al. Interaction of gold nanoparticles with proteins and cells. Sci Technol Adv Mater. 2015;16:034610
   PubMed Web of Science ®Google Scholar
• Iversena T, Skotlanda T, Sandvig K. Endocytosis and intracellular transport of nanoparticles: present knowledge and need for future studies. Nano Today 2011;6:176–185.
   Web of Science ®Google Scholar
• Stern ST, Adiseshaiah PP, Crist RM. Autophagy and lysosomal dysfunction as emerging mechanisms of nanomaterial toxicity. Part Fibre Toxicol. 2012;9:20.
   PubMed Web of Science ®Google Scholar
• Yanes RE, Tarn D, Hwang AA, et al. Involvement of lysosomal exocytosis in the excretion of mesoporous silica nanoparticles and enhancement of the drug delivery effect by exocytosis inhibition. Small. 2013;9:697–704.
   PubMed Web of Science ®Google Scholar
• Steichen SD, Caldorera-Moore M, Peppas NA. A review of current nanoparticle and targeting moieties for the delivery of cancer therapeutics. Eur J Pharm Sci. 2013;48:416–427.
   PubMed Web of Science ®Google Scholar
• Durán N, Silveira CP, Durán M, et al. Silver nanoparticle protein corona and toxicity: a mini-review. J Nanobiotechnol. 2015;13:55
   PubMed Web of Science ®Google Scholar
• Bergin IL, Witzmann FA. Nanoparticle toxicity by the gastrointestinal route: evidence and knowledge gaps. Int J Biomed Nanosci Nanotechnol. 2013;3:163–210.
   PubMedGoogle Scholar
• Lee YK, Choi E, Webster TJ, et al. Effect of the protein corona on nanoparticles for modulating cytotoxicity and immunotoxicity. Int J Nanomedicine. 2015;10:97–113.
   PubMed Web of Science ®Google Scholar
• ter Beek J, Guskov A, Slotboom DJ. Structural diversity of ABC transporters. J Gen Physiol. 2014;143:419–435.
   PubMed Web of Science ®Google Scholar
• Trevisan R, Mello DF, Delapedra G, et al. Gills as a glutathione-dependent metabolic barrier in Pacific oysters Crassostrea gigas: absorption, metabolism and excretion of a model electrophile. Aquat Toxicol. 2016;173:105–119.,
   PubMed Web of Science ®Google Scholar
• Lüchmann KH, Dafre AL, Trevisan R, et al. A light in the darkness: new biotransformation genes, antioxidant parameters and tissue-specific responses in oysters exposed to phenanthrene. Aquat Toxicol. 2014;152:324–334.
   PubMed Web of Science ®Google Scholar
• Abbott NA, Patabendige AA, Dolman DE, et al. Structure and function of the blood-brain barrier. Neurobiol Dis. 2010;37:13–25.
   PubMed Web of Science ®Google Scholar
• Panariti A, Miserocchi G, Rivolta I. The effect of nanoparticle uptake on cellular behavior: disrupting or enabling functions? Nanotechnol Sci Appl. 2012;5:87–100.
   PubMedGoogle Scholar
• Lundquist P, Artursson P. Oral absorption of peptides and nanoparticles across the human intestine: opportunities, limitations and studies in human tissues. Adv Drug Deliv Rev. 2016;106:256–276.
   PubMed Web of Science ®Google Scholar
• Palmer BC, DeLouise LA. Nanoparticle-enabled transdermal drug delivery systems for enhanced dose control and tissue targeting. Molecules. 2016;21:1719.
   Web of Science ®Google Scholar
• Krug HF, Wick P. Nanotoxicology: an interdisciplinary challenge. Angew Chem Int Ed Engl. 2011;50:1260–1278.
   PubMed Web of Science ®Google Scholar
• Arora S, Rajwade JM, Paknikar KM. Nanotoxicology and in vitro studies: the need of the hour. Toxicol Appl Pharmacol. 2012;258:151–15165.
   PubMed Web of Science ®Google Scholar
• Groschwitz KR, Hogan SP. Intestinal barrier function: molecular regulation and disease pathogenesis. J Allergy Clin Immunol. 2009;124:3–20.
   PubMed Web of Science ®Google Scholar
• Ensign LM, Cone R, Hanes J. Oral drug delivery with polymeric nanoparticles: the gastrointestinal mucus barriers. Adv Drug Deliv Rev. 2012;64:557–570.
   PubMed Web of Science ®Google Scholar
• Pardridge WM. Drug transport across the blood-brain barrier. J Cereb Blood Flow Metab. 2012;32:1959–1972.
   PubMed Web of Science ®Google Scholar
• Hersh DS, Wadajkar AS, Roberts N, et al. Evolving drug delivery strategies to overcome the blood brain barrier. Curr Pharm Des. 2016;22:1177–1193.
   PubMed Web of Science ®Google Scholar
• Skruzny M, Desfosses A, Prinz S, et al. An organized co-assembly of clathrin adaptors is essential for endocytosis. Dev Cell. 2015;33:150–162.
   PubMed Web of Science ®Google Scholar
• Nichols JW, Bae YH. EPR: evidence and fallacy. J Control Release. 2014;190:451–464.
   PubMed Web of Science ®Google Scholar
• Danhier F. To exploit the tumor microenvironment: Since the EPR effect fails in the clinic, what is the future of nanomedicine? J Control Release. 2016;244:108–121.
   PubMed Web of Science ®Google Scholar
• Bazak R, Houri M, El Achy S, et al. Cancer active targeting by nanoparticles: a comprehensive review of literature. J Cancer Res Clin Oncol. 2015;141:769–784.
   PubMed Web of Science ®Google Scholar
• Adjei IM, Sharma B, Labhasetwar V. Nanoparticles: cellular uptake and cytotoxicity. Adv Exp Med Biol. 2014;811:73–91.
   PubMed Web of Science ®Google Scholar
• Parkinson-Lawrence EJ, Shandala T, Prodoehl M, et al. Lysosomal storage disease: revealing lysosomal function and physiology. Physiology (Bethesda). 2010;25:102–115.
   PubMed Web of Science ®Google Scholar
• Ni X, Canuel M, Morales CR. The sorting and trafficking of lysosomal proteins. Histol Histopathol. 2006;21:899–913.
   PubMed Web of Science ®Google Scholar
• Sly WS, Vogler C. Brain-directed gene therapy for lysosomal storage disease: going well beyond the blood-brain barrier. Proc Natl Acad Sci USA. 2002;99:5760–5762.
   PubMed Web of Science ®Google Scholar
• Behnke J, Eskelinen EL, Saftig P, et al. Two dileucine motifs mediate late endosomal/lysosomal targeting of transmembrane protein 192 (TMEM192) and a C-terminal cysteine residue is responsible for disulfide bond formation in TMEM192 homodimers. Biochem J. 2011;434:219–231.
   PubMed Web of Science ®Google Scholar
• Kwon EJ, Bergen JM, Pun SH. Application of an HIV gp41-derived peptide for enhanced intracellular trafficking of synthetic gene and siRNA delivery vehicles. Bioconjugate Chem. 2008;19:920–927.
   PubMed Web of Science ®Google Scholar
• Hatakeyama H, Ito E, Akita H, et al. A pH sensitive fusogenic peptide facilitates endosomal escape and greatly enhances the gene silencing of siRNA-containing nanoparticles in vitro and in vivo. J Control Release. 2009;139:127–132.
   PubMed Web of Science ®Google Scholar
• Shrestha R, Elsabahy M, Florez-Malaver S, et al. Endosomal escape and siRNA delivery with cationic shell crosslinked knedel-like nanoparticles with tunable buffering capacities. Biomaterials 2012;33:8557–8856.
   PubMed Web of Science ®Google Scholar
• Varkouhi AK, Scholte M, Storm G, et al. Endosomal escape pathways for delivery of biologicals. J Control Release. 2011;151:220–228.
   PubMed Web of Science ®Google Scholar
• Selbo PK, Weyergang A, Høgset A, et al. Photochemical internalization provides time- and space-controlled endolysosomal escape of therapeutic molecules. J Control Release. 2010;148:2–12.
   PubMed Web of Science ®Google Scholar
• Treuel L, Jiang X, Nienhaus GU. New views on cellular uptake and trafficking of manufactured nanoparticles. J R Soc Interface. 2013;10:20120939.
   PubMed Web of Science ®Google Scholar
• Otomo A, Pan L, Hadano S. Dysregulation of the autophagy-endolysosomal system in amyotrophic lateral sclerosis and related motor neuron diseases. Neurol Res Int. 2012;2012:498428.
   PubMedGoogle Scholar
• Yameen B, Choi WI, Vilos C, et al. Insight into nanoparticle cellular uptake and intracellular targeting. J Control Release. 2014;190:485–499.
   PubMed Web of Science ®Google Scholar
• Khalil IA, Kogure K, Akita H, et al. Uptake pathways and subsequent intracellular trafficking in nonviral gene delivery. Pharmacol Rev. 2006;58:32–45.
   PubMed Web of Science ®Google Scholar
• Fang RH, Hu CM, Zhang L. Nanoparticles disguised as red blood cells to evade the immune system. Expert Opin Biol Ther. 2012;12:385–389.
   PubMed Web of Science ®Google Scholar
• Ehrlich M, Boll W, Van Oijen A, et al. Endocytosis by random initiation and stabilization of clathrin-coated pits. Cell 2004;118:591–605.
   PubMed Web of Science ®Google Scholar
• Conner SD, Schmid SL. Regulated portals of entry into the cell. Nature. 2003;422:37–44.
   PubMed Web of Science ®Google Scholar
• Moreno-Ruiz E, Galan-Diez M, Zhu W, et al. Candida albicans internalization by host cells is mediated by a clathrin-dependent mechanism. Cell Microbiol. 2009;11:1179–1189.
   PubMed Web of Science ®Google Scholar
• Sahay G, Alakhova DY, Kabanov AV. Endocytosis of nanomedicines. J Control Release. 2010;145:182–195.
   PubMed Web of Science ®Google Scholar
• Sandvig K, Pust S, et al. Clathrin-independent endocytosis: mechanisms and function. Curr Opin Cell Biol. 2011;23:413–420.
   PubMed Web of Science ®Google Scholar
• Doherty GJ, Mcmahon HT. Mechanisms of endocytosis. Annu Rev Biochem. 2009;78:857–902.
   PubMed Web of Science ®Google Scholar
• Bohdanowicz M, Grinstein S. Role of phospholipids in endocytosis, phagocytosis, and macropinocytosis. Physiol Rev. 2013;93:69–106.
   PubMed Web of Science ®Google Scholar
• Gabrielson NP, Pack DW. Efficient polyethylenimine-mediated gene delivery proceeds via a caveolar pathway in HeLa cells. J Control Release. 2009;136:54–61.
   PubMed Web of Science ®Google Scholar
• Beddoe T, Paton AW, Le Nours J, et al. Structure, biological functions and applications of the AB5 toxins. Trends Biochem Sci. 2010;35:411–418.
   PubMed Web of Science ®Google Scholar
• Zaki NM, Tirelli N. Gateways for the intracellular access of nanocarriers: a review of receptor-mediated endocytosis mechanisms and of strategies in receptor targeting. Expert Opin. Drug Deliv. 2010;7:895–913.
   PubMed Web of Science ®Google Scholar
• Aberoumandi SM, Mohammadhosseini M, Abasi E, et al. An update on applications of nanostructured drug delivery systems in cancer therapy: a review. Artif Cells Nanomed Biotechnol 2107;45:1–11.
   Google Scholar
• Sharma N, Bhandari S, Deshmukh Yadav AK, et al. Development and characterization of embelin-loaded nanolipid carriers for brain targeting. Artif Cells Nanomed Biotechnol. 2017;45:409–413.
   PubMed Web of Science ®Google Scholar
• Sadat Shandiz SA, Shafiee Ardestani M, Shahbazzadeh D, et al. Novel imatinib-loaded silver nanoparticles for enhanced apoptosis of human breast cancer MCF-7 cells. Artif Cells Nanomed Biotechnol. 2017;45:1–10.
   PubMed Web of Science ®Google Scholar
• Tummala S, Gowthamarajan K, Satish Kumar MN. Oxaliplatin immunohybrid nanoparticles in vitro synergistic suppression evaluation in treatment of colorectal cancer. Artif Cells Nanomed Biotechnol. 2017;45:261–269.
   PubMed Web of Science ®Google Scholar
• Kaur A, Jain K, Mehra NK, et al. of surface engineered PPI dendrimers for targeted drug delivery. Artif Cells Nanomed Biotechnol. 2017;45:414–425.
   PubMed Web of Science ®Google Scholar